Dave Denton

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.

About Dave Denton

Dave Denton is recorded as CFO at Pfizer Inc (PFE). Dave Denton has spoken on 10 earnings calls across 1 company, most recently for Pfizer Inc on May 5, 2026. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), Cecile Guegan (CFO) and 7 others.

Dave Denton on recent calls

“Let me begin by highlighting that our strong first quarter performance reflects the continued disciplined execution across our strategic priorities, and, importantly, continued progress in repositioning the company for sustainable growth.”

CFO, Pfizer Inc Q1 FY2026 Earnings Call · May 5, 2026

“Let me begin today by highlighting that our strong financial performance for both the fourth quarter in the full year directly reflects our continued disciplined execution of our key strategic priorities.”

CFO, Pfizer Inc Q4 FY2025 Earnings Call · February 3, 2026

“I'll begin this morning by reinforcing the fact that our solid financial results demonstrate our strong executional focus. We continue to concentrate on driving positive patient outcomes and delivering on our financial commitments while navigating an ever-complex external environment.”

CFO, Pfizer Inc Q1 FY2025 Earnings Call · April 29, 2025

“I'll build on Albert's comments by reinforcing that we are very pleased with the financial results for both the fourth quarter as well as the full-year of 2024.”

CFO, Pfizer Inc Q4 FY2024 Earnings Call · February 4, 2025

“I will build on Albert's comments by reinforcing that we are very pleased with the financial results for the third quarter of 2024. These results demonstrate that our focus and our execution against our five strategic priorities are driving positive patient outcomes and continued financial and operational strength.”

CFO, Pfizer Inc Q3 FY2024 Earnings Call · December 18, 2024